News | January 03, 2025
Veeda Group rebrands as Veeda Lifesciences
The new brand name reflects the evolution from a generics-focused Contract Research Organization (CRO) to a drug development services enterprise
The new brand name reflects the evolution from a generics-focused Contract Research Organization (CRO) to a drug development services enterprise
Parents, teachers, and caregivers play a vital role in spotting early signs of schizophrenia
The TGA approval marks a pivotal step in Rusan Pharma’s expansion into the Australian market
Esketamine hydrochloride is a vital drug to be used for treating mental illness and is likely to significantly impact the LATAM market
Aims to become India’s leading cancer testing company
She will be responsible in this role for Finance & Controlling, HR Services and IT Management at Romaco Holding
The first and only immuno-oncology drug approved for the treatment of nasopharyngeal carcinoma
The new facility significantly increases Siegfried’s R&D capacity to drive development excellence and further growth
With 6 operation hubs and 18 offices across North America, Europe, and Asia, Indegene’s client base includes the world’s top 20 biopharma companies
Recommendation based on LAURA Phase III trial results which showed Tagrisso extended median progression-free survival to more than three years
Subscribe To Our Newsletter & Stay Updated
